Publication | Closed Access

Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation

Hematological MalignancyTransplantationMarrow TransplantationMedicineAcute Myeloid LeukemiaMixed-phenotype Acute LeukemiaHematologyMyeloid NeoplasiaStem Cell TransplantationHigh-dose ChemotherapyBlood TransplantationRadiation OncologyOncologyCell TransplantationClinical OutcomeHealth Sciences